Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 3706 AL 3720

Prioritizing Parkinson's disease risk genes in genome-wide association loci

Lange LM, Cerquera-Cleves C, Schipper M, Panagiotaropoulou G, Braun A, Kraft J, Awasthi S, Bell N, Posthuma D, Ripke S, Blauwendraat C, Heilbron K.

medRxiv [Preprint]. 2024 Dec 14:2024.12.13.24318996. doi: 10.1101/2024.12.13.24318996.

Cervical percutaneous interferential current stimulation improves citric acid cough tests in patients with Parkinson's disease on medication

Nakamori M, Toko M, Yamada H, Hayashi Y, Ushio K, Yoshikawa K, Hiraoka A, Yoshikawa M, Nagasaki T, Shimizu Y, Mikami Y, Maruyama H.

Sci Rep. 2024 May 18;14(1):11386. doi: 10.1038/s41598-024-62460-x.

Modeling and Optimizing Deep Brain Stimulation to Enhance Gait in Parkinson's Disease: Personalized Treatment with Neurophysiological Insights

Azgomi HF, Louie KH, Bath JE, Presbrey KN, Balakid JP, Marks JH, Wozny TA, Galifianakis NB, Luciano MS, Little S, Starr PA, Wang DD.

medRxiv [Preprint]. 2024 Nov 1:2024.10.30.24316305. doi: 10.1101/2024.10.30.24316305.

Let Us Talk Money: Subjectively Reported Financial Performance of People Living with Neurodegenerative Diseases-A Systematic Review

Ariesen AD, Tuomainen RE, De Deyn PP, Tucha O, Koerts J.

Neuropsychol Rev. 2024 Jun;34(2):668-719. doi: 10.1007/s11065-023-09597-0. Epub 2023 Aug 18.

Development of quantitative high-throughput screening assays to identify, validate, and optimize small-molecule stabilizers of misfolded β-glucocerebrosidase with therapeutic potential for Gaucher disease and Parkinson's disease

Williams D, Glasstetter LM, Jong TT, Kapoor A, Zhu S, Zhu Y, Gehrlein A, Vocadlo DJ, Jagasia R, Marugan JJ, Sidransky E, Henderson MJ, Chen Y.

bioRxiv [Preprint]. 2024 Mar 27:2024.03.22.586364. doi: 10.1101/2024.03.22.586364.

Genetic screening and metabolomics identify glial adenosine metabolism as a therapeutic target in Parkinson's disease

Sodders MJ, Avila-Pacheco J, Okorie EC, Shen M, Kumari N, Marathi A, Lakhani M, Bullock K, Pierce K, Dennis C, Jeanfavre S, Sarkar S, Scherzer CR, Clish C, Olsen AL.

bioRxiv [Preprint]. 2024 Jun 2:2024.05.15.594309. doi: 10.1101/2024.05.15.594309.

Peripheral immune cell response to stimulation stratifies Parkinson's disease progression from prodromal to clinical stages

Mark JR, Titus AM, Staley HA, Alvarez S, Mahn S, McFarland NR, Wallings RL, Tansey MG.

bioRxiv [Preprint]. 2024 Dec 7:2024.12.05.625499. doi: 10.1101/2024.12.05.625499.

The effect of dysautonomia on motor, behavioral and cognitive fluctuations in Parkinson's disease

Mahajan A, Morrow CB, Seemiller J, Mills KA, Pontone GM.

medRxiv [Preprint]. 2024 Aug 26:2024.08.26.24312589. doi: 10.1101/2024.08.26.24312589.

Imaging spatial transcriptomics reveals molecular patterns of vulnerability to pathology in a transgenic α-synucleinopathy model

Horan-Portelance L, Iba M, Acri DJ, Gibbs JR, Cookson MR.

bioRxiv [Preprint]. 2024 Dec 14:2024.07.31.606032. doi: 10.1101/2024.07.31.606032.

14-3-3 binding maintains the Parkinson's associated kinase LRRK2 in an inactive state

Martinez Fiesco JA, Li N, Alvarez de la Cruz A, Metcalfe RD, Beilina A, Cookson MR, Zhang P.

bioRxiv [Preprint]. 2024 Nov 22:2024.11.22.624879. doi: 10.1101/2024.11.22.624879.

Long-read sequencing unravels the complexity of structural variants in PRKN in two individuals with early-onset Parkinson's disease

Cogan G, Daida K, Billingsley KJ, Tesson C, Forlani S, Jornea L, Arnaud L, Tissier L, LeGuern E, Singleton AB, Ferrien M, Gervais Bernard H, Lesage S, Blauwendraat C, Brice A.

medRxiv [Preprint]. 2024 May 3:2024.05.02.24306523. doi: 10.1101/2024.05.02.24306523.

Meta-analysis on the interrelationship between sarcopenia and mild cognitive impairment, Alzheimer's disease and other forms of dementia

Amini N, Ibn Hach M, Lapauw L, Dupont J, Vercauteren L, Verschueren S, Tournoy J, Gielen E.

J Cachexia Sarcopenia Muscle. 2024 Aug;15(4):1240-1253. doi: 10.1002/jcsm.13485. Epub 2024 May 7.

Pre-trained Convolutional Neural Networks Identify Parkinson's Disease from Spectrogram Images of Voice Samples

Rahmatallah Y, Kemp A, Iyer A, Pillai L, Larson-Prior L, Virmani T, Prior F.

Res Sq [Preprint]. 2024 Dec 18:rs.3.rs-5348708. doi: 10.21203/rs.3.rs-5348708/v1.

Azaspirooctane-carboxylates as Novel Activators/Modulators of M4 for the Treatment of Alzheimer's Disease and Parkinson's Disease

Rosse G.

ACS Med Chem Lett. 2024 Nov 4;15(11):1830-1831. doi: 10.1021/acsmedchemlett.4c00512. eCollection 2024 Nov 14.

Understanding REM Sleep Behavior Disorder through Functional MRI: A Systematic Review

Churchill L, Chen YC, Lewis SJG, Matar E.

Mov Disord. 2024 Oct;39(10):1679-1696. doi: 10.1002/mds.29898. Epub 2024 Jun 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias